| 03:21 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 08:54 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
|
| 08:45 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 09:15 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 04:52 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 11:54 AM |
Response To Query Dated Feb 1, 2026 - Clarification On Volume Movement In The Equity Shares Of The Company
|
| 12:42 PM |
Clarification sought from Strides Pharma Science Ltd
|
| 03:49 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:38 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 01:00 PM |
Board Meeting Outcome for Outcome Of Board Meeting - Financial Results Q3 FY 26
|
| 12:56 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 12:54 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 12:49 PM |
Un-Audited Financial Results (Consolidated & Standalone)
For The Quarter And Nine Months Ended December 31, 2025
|
| 09:38 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 07:12 PM |
Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 03:07 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 06:34 PM |
Completion Of US-FDA Inspection At The Formulations Facility Of Strides Pharma Inc., USA, A Step-Down Wholly Owned Subsidiary Of The Company
|
| 05:55 PM |
Closure of Trading Window
|
| 11:47 AM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 06:01 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 03:35 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 09:46 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 06:55 PM |
Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 03:18 PM |
Strides And Incepta Partner To Expand Women'S Health Access With WHO-Prequalified Contraceptive
|
| 02:57 PM |
Closure of Trading Window
|
| 06:02 PM |
2Nd Reminder To Shareholders Whose Shares Are Due To Be Transferred To IEPF
|
| 06:39 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 06:22 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 05:36 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 05:28 PM |
Deregistration Of A Non-Operating Step-Down Subsidiary Of The Company In South Africa
|
| 09:09 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 08:25 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 04:32 PM |
Shareholder Meeting / Postal Ballot-Outcome of AGM
|
| 07:08 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 06:01 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:57 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 12:48 PM |
Board Meeting Outcome for Allotment Of Shares Under ESOP Scheme
|
| 12:44 PM |
Amendment To Code Of Fair Disclosure Of UPSI
|
| 12:41 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 12:37 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 12:33 PM |
Financial Results (Consolidated & Standalone) For The Quarter Ended June 30, 2025
|
| 08:57 PM |
Change In Statutory Auditors Of Material Subsidiary Of The Company In UK
|
| 05:56 PM |
Reminder To Shareholders About Transfer Of Equity Shares Relating To Unclaimed Dividend Of The Company To Investor Education And Protection Fund ('IEPF')
|
| 07:17 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 07:04 PM |
Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 06:39 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 03:35 PM |
Business Responsibility and Sustainability Reporting (BRSR)
|
| 03:32 PM |
Reg. 34 (1) Annual Report.
|
| 03:23 PM |
Notice Of 34Th Annual General Meeting
|
| 05:50 PM |
No Objection Letter Received From Stock Exchanges.
|
| 12:24 PM |
Intimation Regarding Communication To Shareholders On TDS For Final Dividend For FY 2024-25
|
| 12:13 PM |
Intimation Regarding Communication To Shareholders On TDS For Final Dividend For FY 2024-25
|
| 01:47 PM |
Intimation To Members About Record Date For The Purpose Of Final Dividend For FY25.
|
| 07:23 PM |
Announcement under Regulation 30 (LODR)-Restructuring
|
| 06:31 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 05:33 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 12:12 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 06:15 PM |
Intimation Pursuant To Regulation 31A Of The Sebl (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Promoter Reclassification
|
| 05:31 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 07:12 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 01:45 PM |
Board Meeting Outcome for Outcome Of Board Meeting Held On May 22, 2025
|
| 01:42 PM |
Update On Promoters Reclassification Request
|
| 01:40 PM |
Appointment Of Secretarial Auditor
|
| 01:39 PM |
Corporate Action-Board approves Dividend
|
| 01:37 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 01:33 PM |
Outcome Of Board Meeting Of The Company Held On May 22, 2025
|
| 09:21 PM |
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
|
| 09:17 PM |
Intimation Under Regulation 31A Of SEBI Listing Regulations
|
| 09:11 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 09:07 PM |
Board Meeting Intimation for Intimation On Board Meeting
|
| 12:28 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 03:04 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 06:31 PM |
Strides Acquires Identified Andas From Nostrum Laboratories, Inc., USA
|
| 12:16 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 12:08 PM |
Intimation For Change In Details Of Key Managerial Personnel For Determining Materiality Of Events Or Information And Making Disclosure To Stock Exchange Under Regulation 30 Of SEBI Listing Regulations
|
| 06:22 PM |
Update On Redemption Of Secured, Unlisted, Redeemable, Non-Convertible Debentures
|
| 03:59 PM |
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
|
| 03:52 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
|
| 05:25 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 11:49 AM |
Proposed De-Merger Of Identified Business Of Arco Lab Private Limited ('Arco Lab'), A Wholly Owned Subsidiary Of The Company
|
| 05:12 PM |
Dissolution
|
| 06:07 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 10:40 AM |
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
|
| 06:43 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:00 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 03:19 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 05:24 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:26 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 04:38 PM |
Integrated Filing (Financial)
|
| 01:31 PM |
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
|
| 01:30 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 01:27 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 01:24 PM |
Board Meeting Outcome for Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2024
|
| 01:21 PM |
Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2024
|
| 07:59 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 06:45 PM |
Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 Of SEBI Listing Regulations
|
| 11:06 AM |
Onesource Specialty Pharma Limited (Onesource) - India'S First Specialty Pharma CDMO Receives Listing And Trading Approval For Its Equity Shares From BSE And NSE.
Onesource To Start Trading In NSE And BSE From January 24, 2025
|
| 11:05 AM |
Strides Pharma Debuts With A Stellar ESG Rating Of 76/100 In The S&P Global''s Corporate Sustainability Assessment (CSA) 2024
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback